ARIAD to Present at the Leerink Swann Global Healthcare Conference

  ARIAD to Present at the Leerink Swann Global Healthcare Conference

Leerink Swann Global Healthcare Conference

Business Wire

CAMBRIDGE, Mass. -- February 8, 2013

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the Leerink Swann Global Healthcare Conference being held in New
York City. Harvey J. Berger, M.D., chairman and chief executive officer, will
provide an overview of the Company’s business on Thursday, February 14, at
9:00 a.m. (ET).

The ARIAD presentation at the Leerink Swann Global Healthcare Conference will
be webcast live and can be accessed by visiting the investor relations section
of the Company's website at http://www.ariad.com/investor. A replay of the
presentation will also be available and archived on the site for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and
Lausanne, Switzerland, is an integrated global oncology company focused on
transforming the lives of cancer patients with breakthrough medicines. ARIAD
is working on new medicines to advance the treatment of various forms of
chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer medicines.
For additional information, visit http://www.ariad.com or follow ARIAD on
Twitter (@ARIADPharm).

Contact:

ARIAD Pharmaceuticals, Inc.
For Investors
Kendra Adams, 617-503-7028
Kendra.adams@ariad.com
or
For Media
Liza Heapes, 617-621-2315
Liza.heapes@ariad.com
 
Press spacebar to pause and continue. Press esc to stop.